Epinephrine Autoinjectors Underused in Adults With Unexplained Anaphylaxis
Driven by issues concerning epinephrine autoinjector supply and costs, a new research study by researchers from Seattle Children’s Hospital and the University of Washington sought to determine the safety of prefilled syringes for anaphylaxis treatment. Find out what researchers determined about degradation and bacterial growth in those products.

Here’s How Infants With Anaphylaxis Should Be Treated
Fewer than 2 years ago, the FDA approved an epinephrine autoinjector for infants weighing between 7.5 and 15 kg. That raises the question of how infants with anaphylaxis should be treated, and an expert panel took on the challenge of answering it. Here are some of its recommendations.